Skip to main content

2 Result(s)

within Drug Resistance Remove this filter Molecular Medicine Remove this filter Matteo Dugo Remove this filter Article Remove this filter

and

  1. Article

    Open Access

    Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy

    Luminal breast cancers with high proliferation (MKShi) and low ER-related signalling (ERSlo) have a poor prognosis. We investigated treatment responses and molecular features of MKShi/ERSlo tumours to inform pote...

    Luca Licata, Marco Barreca, Barbara Galbardi, Matteo Dugo… in British Journal of Cancer (2023)

    Download PDF (1202 KB) View Article

  2. Article

    Open Access

    Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma

    Anthracycline-containing regimens, namely cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or CHOEP (CHOP + etoposide), represent the current standard of care for patients with newly diagnosed ...

    Martina Magni, Giulia Biancon, Sara Rizzitano… in British Journal of Cancer (2019)

    Download PDF (2006 KB) View Article